CN109867717A - The extracting method of 1 microglobulin of α in a kind of blood plasma - Google Patents
The extracting method of 1 microglobulin of α in a kind of blood plasma Download PDFInfo
- Publication number
- CN109867717A CN109867717A CN201910257872.9A CN201910257872A CN109867717A CN 109867717 A CN109867717 A CN 109867717A CN 201910257872 A CN201910257872 A CN 201910257872A CN 109867717 A CN109867717 A CN 109867717A
- Authority
- CN
- China
- Prior art keywords
- microglobulin
- buffer
- blood plasma
- extracting method
- ammonium sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a kind of extracting method of 1 microglobulin of α in blood plasma, successively follow the steps below it is obtained, 1) take 1 microglobulin of α immune after sheep blood plasma, many kinds of substance such as initial gross separation haemocyte after sedimentation;2) centrifuging and taking supernatant reaches 33%(w/v using ammonium sulfate precipitation to solution ammonium sulfate end saturated concentration) precipitate serum sufficiently;3) precipitation and separation sufficiently redissolves, and dialyses and is concentrated;4) initial gross separation is carried out to the processed filtrate of step 3) using gel permeation chromatography column, collects the eluent containing 1 microglobulin of α;5) eluent being collected into using Protein G affinity column to step 4) carries out affinity chromatography, collects filtrate and carries out after desalination, concentration up to 1 microglobulin of α;6) 1 microglobulin purity of α is identified using SDS-PAGE.This method step is simple, highly-safe, and stability is high and acquisition purity of protein is higher, is suitble to laboratory and enlarged experiment production.
Description
Technical field
The invention belongs to protein separation fields, more particularly, to a kind of extraction side of 1 microglobulin of α in blood plasma
Method.
Background technique
1 microglobulin of α (alpha 1-microglobulin, α 1-MG) be relative molecular mass about 26000 in human body ~
The micro-molecule glucoprotein of 33000KDa is usually made of 182 amino acid residues, earliest by Ekstrom etc. from Chronic Cadmium
It separated in the urine of malicious patient, purify and obtain, be located at 1 zone of α when electrophoresis and gain the name.Its unique size and charge it is inhomogenous
Property, so that function is become particularly significant.It is widely distributed in vivo as the important indicator for judging liver and renal function, mainly by
After liver cell or lymphocyte specific synthesis, it is assigned in internal various tissues with blood transportation.In blood, 1 microballoon egg of α
The white form that is primarily present is with the presence of free and Immunoglobulin IgA or albumin combining form.When severe hepatic disorder,
Since liver cell is impaired, reduce liver synthesis, metabolism and secretion α 1-MG, α 1-MG content reduces in hepatopathy patient serum.
Sequestered α 1-MG can freely through glomerular filtration membrane, but at proximal convoluted tubule because reabsorption almost again be absorbed, together
When combining form α 1-MG cannot may only detect sequestered α 1- in the urine of normal condition servant by glomerular filtration
The presence of MG, once it will lead to combine since detection of glomeruli filtration function is impaired or reabsorption and metabolic capability reduce
Form α 1-MG is more discharged into urine by blood, and the content of α 1-MG is caused to increase.Therefore, α 1-MG is as screening early stage
Nephrosis, the important indicator of hepatopathy, in clinic, the various aspects such as outpatient service and Gernral Check-up are widely used.
Since α 1-MG is widely used in medical diagnosis on disease, developing efficient purification schemes has significantly
Realistic meaning and application value.The relevant method of purification of existing report is more complicated, cumbersome and costly, sees Shen Xin
Justice etc. " separation of human urine 1-microglobulin of α, purifying and identification " (The 2nd Army Medical College journal, 1992,13), biography used
The fiber medium DE52/CM52 of system, flow velocity is slow, and effect of living again is poor, and the service life is short, is not suitable for quantization production.
Summary of the invention
Problem to be solved by this invention is just to provide a kind of extracting method of 1 microglobulin of α in blood plasma, for preparation diagnosis
Antibody starting material provides basis in kit, and its technical solution is as follows:
The extracting method of 1 microglobulin of α in a kind of blood plasma, comprising the following steps:
1) the fresh sheep blood plasma after taking 1 microglobulin antigen of α immune, after waiting for blood to solidify, takes blood plasma to be centrifuged off fibrin
Light yellow transparent liquid-serum is isolated after former and certain coagulation factors;
2) upper layer light yellow transparent liquid is sucked out in siphonage, is precipitated to solution ammonium sulfate end saturated concentration using ammonium sulfate precipitation method
Reach 33%(w/v).After serum sufficiently precipitates, precipitating is redissolved using the kaliumphosphate buffer of pH7.5, using normal saline solution
Dialysis, using PEG20000 protein concentrate.
3) chromatographic column equipped with sephadex G100 filler is taken, uses the kaliumphosphate buffer of pH7.5 as equilibration buffer
The chromatographic column is balanced, then loading is eluted with same buffer with 0.5 mL/min, collect eluent, dense with PEG20000
Contracting collection liquid.
4) chromatography that the homogenate of Protein G affinity chromatography medium is pre-loaded with 1mL Binding Buffer to one is drawn
In column, allows filler filler natural subsidence to bottom of the pillar, 5 mL Binding Buffer are added into column, make Buffer slow
Outflow, flow velocity 1mL/min.Concentrate in step 3) Binding Buffer 1:1 is diluted, starts to be loaded, flow velocity is about
For 0.2-0.5 mL/min, efflux is collected, it is subsequent to detect purification efficiency with SDS-PAGE.Use about 30 mL Binding
Buffer washing, flow velocity are about 2 mL/min, and the absorbance at frontier inspection survey 280nm is washed on side, until there is stationary value.Washing
After, it is initially added into 10-15 mL Elution Buffer, using 1 mL/min compared with low flow velocity, collects eluent, then adjust
PH to 7.4, as pure 1 microglobulin of α.Wherein Binding Buffer are as follows: 20Mm NaHPO4,0.15M NaCl, pH
8.0.Elution Buffer are as follows: 0.1 M glycine pH 2.5.
5) 1 microglobulin purity of α is identified using SDS-PAGE.Using 12% separation gel, 5% concentration glue takes 50 μ L samples molten
Liquid adds 10 μ L 10x sample buffers to be uniformly mixed, and boils 5min, and 12000rpm is centrifuged 5min loading.
The beneficial effects of the present invention are:
In method provided by the invention, the sephadex G100 used, this glue pH range is wide, and carrying capacity is big, is more suitable for α 1-MG
Purifying, and integrated operation is easy, and repeatability is strong, and single operation output is big.
Detailed description of the invention
Fig. 1 is 1 microglobulin SDS-PAGE map of α after purification of the embodiment of the present invention.
Specific embodiment
With reference to the accompanying drawing and specific embodiment is further elaborated the contents of the present invention, but embodiment is only this
The better embodiment of invention, therefore all equivalence changes done according to feature described in present patent application range and principle,
It is included in the scope of the patent application of the present invention.
Embodiment 1:
The first step, the sheep blood plasma after taking 1 microglobulin of α immune, natural subsidence is stayed overnight under room temperature, next day at 4 DEG C, 4000xg from
Heart 15min, removal red blood cell, leucocyte, blood platelet go out etc. a variety of haemocytes;
Second step is sucked out upper layer light yellow transparent liquid, is precipitated to solution ammonium sulfate end saturated concentration using ammonium sulfate precipitation method
Reach 33%(w/v), it is placed in 4 DEG C of overnight precipitations.After serum sufficiently precipitates, next day, 8000xg was centrifuged 20min, in abandoning at 4 DEG C
Clearly, precipitating is collected.Precipitating is redissolved using the kaliumphosphate buffer of pH7.5, and saturating overnight at 4 DEG C using normal saline solution
Analysis, to remove a large amount of ammonium sulfate having in serum deprivation, after dialysis, using PEG20000 protein concentrate;
Third step takes the chromatographic column (2cm*60cm) equipped with sephadex G100 filler, is made with the kaliumphosphate buffer of pH7.5
Then use same buffer with 0.5 mL/ the concentrate loading in second step for chromatographic column described in equilibration buffer
The flow velocity of min elutes, while detecting the absorbance at 280nm, collects eluent until the absorbance appearance at 280nm is constant
Collection liquid is concentrated with PEG20000 in value.
4th step draws the homogenate of Protein G affinity chromatography medium to one and is pre-loaded with 1mL Binding Buffer
Chromatographic column in, allow filler filler natural subsidence to bottom of the pillar, 5 mL Binding Buffer be added into column, allow
Buffer slowly flows out, flow velocity 1mL/min.Concentrate in step 3) Binding Buffer 1:1 is diluted, is started
Sample-adding, flow velocity is about 0.2-0.5 mL/min, collects efflux, subsequent to detect purification efficiency with SDS-PAGE.Use about 30
ML Binding Buffer washing, flow velocity are about 2 mL/min, and the absorbance at frontier inspection survey 280nm is washed on side, until occurring
Stationary value.After washing, it is initially added into 10-15 mL Elution Buffer, using 1 mL/min compared with low flow velocity, collection is washed
De- liquid, then pH is adjusted to 7.4.Wherein Binding Buffer are as follows: 20Mm NaHPO4,0.15M NaCl, pH 8.0.Elution
Buffer are as follows: 0.1 M glycine pH 2.5.It is concentrated later with the ultrafiltration membrane that interception is 10KD, as pure 1 microballoon of α
Albumen.
5th step identifies 1 microglobulin purity of α using SDS-PAGE.Using 12% separation gel, 5% concentration glue takes 50 μ L
Sample solution adds 10 μ L 10x sample buffers to be uniformly mixed, and boils 5min, samples 10 μ L addition after 12000rpm centrifugation 5min
Gel loading wells.Electrophoresis apparatus is connected, adjustment voltage to 80 V uses 130 V instead after sample fully enters gel, starts electrophoresis
Until bromophenol blue indicator reaches gel bottom.Blob of viscose is placed in distillation water washing 2 times after electrophoresis, then is placed in R-250 dye
It is dyed overnight in color liquid, distillation water washing decoloration, testing goal albumen.
The 1 microglobulin molecule amount of α that the present embodiment obtains is 35KDa, and the purity of 1 microglobulin of α is 90%, and the rate of recovery is
85%。
1 microglobulin SDS-PAGE map of α is as shown in Figure 1 after purification for method provided by the invention.
In Fig. 1, the sample after respectively Maker, sheep blood serum sample, 33% ammonium sulfate precipitation sheep blood serum, sheep from left to right
Sample after serum affinitive layer purification.
Finally, it should be noted that the foregoing is only a preferred embodiment of the present invention, it is not intended to restrict the invention,
Although the present invention is described in detail referring to the foregoing embodiments, for those skilled in the art, still may be used
To modify the technical solutions described in the foregoing embodiments or equivalent replacement of some of the technical features.
All within the spirits and principles of the present invention, any modification, equivalent replacement, improvement and so on should be included in of the invention
Within protection scope.
Claims (6)
1. the extracting method of 1 microglobulin of α in a kind of blood plasma, which is characterized in that comprise the following steps:
1) the fresh sheep blood plasma after taking 1 microglobulin antigen of α immune, after waiting for blood to solidify, takes blood plasma to be centrifuged off fibrin
Light yellow transparent liquid-serum is isolated after former and certain coagulation factors;
2) upper layer light yellow transparent liquid is sucked out in siphonage, precipitates serum sufficiently using ammonium sulfate precipitation method, and centrifuge separation is heavy
It forms sediment, precipitating is redissolved in buffer, after sufficiently redissolving, dialyse, be concentrated;
3) gel permeation chromatography;
4) Protein G affinity chromatography;
5) SDS-PAGE method identifies 1 microglobulin purity of α.
2. the extracting method of 1 microglobulin of α in blood plasma according to claim 1, it is characterised in that: the centrifugal condition is
At 4 DEG C, 4000xg is centrifuged 15min.
3. the extracting method of 1 microglobulin of α in blood plasma according to claim 1, it is characterised in that: the ammonium sulfate precipitation
Method is precipitated to solution ammonium sulfate end saturated concentration and reaches 33%(w/v) precipitate serum sufficiently.
4. the extracting method of 1 microglobulin of α in blood plasma according to claim 1, it is characterised in that: the precipitating is redissolved slow
Fliud flushing uses the kaliumphosphate buffer of pH7.5, and elution buffer uses normal saline solution, using PEG20000 protein concentrate.
5. the extracting method of 1 microglobulin of α in blood plasma according to claim 1, it is characterised in that: the step 3) is specific
Are as follows: the chromatographic column equipped with sephadex G100 filler is taken, uses the kaliumphosphate buffer of pH7.5 as equilibration buffer institute
Chromatographic column is stated, then loading is eluted with same buffer with 0.5 mL/min, collect eluent, be concentrated with PEG 20000
Collection liquid.
6. the extracting method of 1 microglobulin of α in blood plasma according to claim 1, it is characterised in that: the step 4) is specific
Are as follows: it draws the homogenate of Protein G affinity chromatography medium and is pre-loaded with to one in the chromatographic column of 1mL Binding Buffer, allowed
Filler filler natural subsidence is added 5 mL Binding Buffer into column, Buffer is allowed slowly to flow out, flow to bottom of the pillar
Speed is 1mL/min;Concentrate in step 3) Binding Buffer 1:1 is diluted, starts to be loaded, flow velocity is about 0.2-
0.5 mL/min collects efflux, subsequent to detect purification efficiency with SDS-PAGE;Use about 30 mL Binding Buffer
Washing, flow velocity are about 2 mL/min, and the absorbance at frontier inspection survey 280nm is washed on side, until there is stationary value;Washing finishes
Afterwards, be initially added into 10-15 mL Elution Buffer, using 1 mL/min compared with low flow velocity, collect eluent, then adjust pH to
7.4, as pure 1 microglobulin of α;Wherein Binding Buffer are as follows: 20Mm NaHPO4,0.15M NaCl, pH 8.0;
Elution Buffer are as follows: 0.1 M glycine pH 2.5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910257872.9A CN109867717A (en) | 2019-04-01 | 2019-04-01 | The extracting method of 1 microglobulin of α in a kind of blood plasma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910257872.9A CN109867717A (en) | 2019-04-01 | 2019-04-01 | The extracting method of 1 microglobulin of α in a kind of blood plasma |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109867717A true CN109867717A (en) | 2019-06-11 |
Family
ID=66921740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910257872.9A Pending CN109867717A (en) | 2019-04-01 | 2019-04-01 | The extracting method of 1 microglobulin of α in a kind of blood plasma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109867717A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114460190A (en) * | 2022-01-19 | 2022-05-10 | 西安乐析医疗科技有限公司 | Method for measuring content of beta 2-microglobulin |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101857635A (en) * | 2010-04-28 | 2010-10-13 | 天津商业大学 | Continuous separation method for three proteins in bovine plasma |
CN103119058A (en) * | 2010-07-23 | 2013-05-22 | 巴克斯特国际公司 | Manufacture of inter -alpha - inhibitor proteins (IAIP) from plasma |
WO2015042593A1 (en) * | 2013-09-23 | 2015-03-26 | Assaypro, Llc | Immunoassays using over-labeled fluorescent probes |
CN104661673A (en) * | 2012-09-05 | 2015-05-27 | A1M制药公司 | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases |
CN105153297A (en) * | 2015-09-17 | 2015-12-16 | 中国人民解放军军事医学科学院野战输血研究所 | Method for separating and purifying alpha2-macroglobulin from Cohn component IV precipitate |
CN106053840A (en) * | 2016-07-12 | 2016-10-26 | 安徽伊普诺康生物技术股份有限公司 | Kit for measuring alpha1-microglobulin and preparation method of kit |
CN107430134A (en) * | 2015-03-16 | 2017-12-01 | A1M制药公司 | The biomarker of preeclampsia |
-
2019
- 2019-04-01 CN CN201910257872.9A patent/CN109867717A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101857635A (en) * | 2010-04-28 | 2010-10-13 | 天津商业大学 | Continuous separation method for three proteins in bovine plasma |
CN103119058A (en) * | 2010-07-23 | 2013-05-22 | 巴克斯特国际公司 | Manufacture of inter -alpha - inhibitor proteins (IAIP) from plasma |
CN104661673A (en) * | 2012-09-05 | 2015-05-27 | A1M制药公司 | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases |
WO2015042593A1 (en) * | 2013-09-23 | 2015-03-26 | Assaypro, Llc | Immunoassays using over-labeled fluorescent probes |
CN107430134A (en) * | 2015-03-16 | 2017-12-01 | A1M制药公司 | The biomarker of preeclampsia |
CN105153297A (en) * | 2015-09-17 | 2015-12-16 | 中国人民解放军军事医学科学院野战输血研究所 | Method for separating and purifying alpha2-macroglobulin from Cohn component IV precipitate |
CN106053840A (en) * | 2016-07-12 | 2016-10-26 | 安徽伊普诺康生物技术股份有限公司 | Kit for measuring alpha1-microglobulin and preparation method of kit |
Non-Patent Citations (5)
Title |
---|
单虎: "《现代兽医兽药大全 动物生物制品分册》", 30 April 2011, 中国农业大学出版社 * |
程之: "《病理化验诊断指南》", 30 June 1999, 中国纺织出版社 * |
郎江明: "《临床免疫诊断学》", 31 January 2003, 广东科技出版社 * |
陆学军等: "人尿中α1微球蛋白的分离纯化和鉴定", 《临床检验杂志》 * |
魏雁虹等: "慢性乙型肝炎患者血清α1微球蛋白检测的临床意义", 《吉林大学学报(医学版)》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114460190A (en) * | 2022-01-19 | 2022-05-10 | 西安乐析医疗科技有限公司 | Method for measuring content of beta 2-microglobulin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3663684A (en) | Carcinoembryonic antigen and diagnostic method using radioactive iodine | |
McGarry et al. | The isolation and electrophoretic characterization of the proteins in the urine of normal subjects | |
CA1086235A (en) | Continuous removing system of blood substances by extra corporeal circulation | |
CN105153297B (en) | Method for separating and purifying α 2-macroglobulin from Cohn component IV precipitate | |
Turner et al. | Characterization of human antibodies to Salmonella typhi by gel-filtration and antigenic analysis | |
CN111961637A (en) | Extracellular vesicle separation method based on combination of size exclusion chromatography and ultrafiltration | |
IE47092B1 (en) | New glycoprotein and process for isolating it | |
CN109867717A (en) | The extracting method of 1 microglobulin of α in a kind of blood plasma | |
Herscowitz et al. | Immunochemical and immunogenic properties of a purified keyhole limpet haemocyanin | |
CA1213212A (en) | Protein (pp in17 xx), a process for concentrating and isolating it and its use | |
CA1187076A (en) | Protein pp.sub.9, process for its enrichment and its isolation and its use | |
US4746731A (en) | Isolated tissue protein PP18 | |
Harvey et al. | Demonstration of two molecular variants of carcinoembryonic antigen by concanavalin A sepharose affinity chromatography | |
CN104984739B (en) | A kind of preparation method and applications of gelatin affinity chromatography medium | |
CN101045750B (en) | Extraction process of camel colostrum immune globulin IgA, IgG. | |
JPS60104015A (en) | Novel protein pp20 and method of obtaining same | |
CA1243014A (en) | Tissue protein pp in21 xx, a process for obtaining it and its use | |
CN106432406A (en) | Preparation method of sika deer coronet micromolecular protein monomer | |
CN115819591A (en) | Anti-erythrocyte membrane antibody and application thereof | |
CN108660125A (en) | A method of extracting neutrophil leucocyte azurophilic granule in transfusing blood waste from human body | |
US4599318A (en) | Tissue protein PP19, a process for obtaining it, and its use | |
Freedman et al. | The heterogeneity of gamma-globulin in post-exercise urine | |
CN114605552B (en) | Antibody for diagnosing inflammatory bone diseases and preparation method thereof | |
CN208552669U (en) | A kind of Almightiness type plasma purification system based on centrifugal separation plasma method | |
CN105753974A (en) | Ulinastatin purification method based on affinity chromatography column |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190611 |
|
RJ01 | Rejection of invention patent application after publication |